Search Critical Intelligence Unit
Debug info
Current query string:
Current Matrix GET variables:
{"resultsTemplateID":"687182","collection":"aci-ciu"} Reset search page
Link to REST URL
1 - 10 of 729 results found.
Omicron (B.1.1.529) variant evidence check
COVID-19 Critical Intelligence Unit: Omicron (B.1.1.529). 1. In brief. Omicron (B.1.1.529) updated 27 January 2022. Summary. • Omicron (B.1.1.529) was designated a variant of concern by the World Health Organization on 26. November 2021. It was
Document | File size: 188.9 KB | Date: 10/12/2021
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0008/696743/Evidence-Check-Omicron.pdf
COVID-19 Critical Intelligence Unit: Sotrovimab. 1. In brief. Sotrovimab 21 January 2022. Introduction. • Sotrovimab (XEVUDY), is a monoclonal antibody treatment for COVID-19.1. • Monoclonal antibodies are proteins, made in the laboratory, that
Document | File size: 231.3 KB | Date: 21/01/2022
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0012/695982/Evidence-Check-Sotrovimab.pdf
Emerging variants evidence check
COVID-19 Critical Intelligence Unit: Emerging variants. 1. In brief. Emerging variants 13 May 2022. Summary. • The World Health Organization is monitoring BA.1, BA.2, BA.3, BA.4, BA.5 and descendent. lineages and BA.1/BA.2 circulating recombinant
Document | File size: 146.8 KB | Date: 18/03/2022
COVID-19 Critical Intelligence Unit: Molnupiravir. 1. In brief. Molnupiravir 24 November 2021. Summary. • Molnupiravir (MK-4482/EIDD-2801), is an antiviral medication that is administered orally.1. • Molnupiravir is a potent ribonucleoside
Document | File size: 143.3 KB | Date: 24/11/2021
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0009/686466/Evidence-Check-Molnupiravir.pdf
Monoclonal antibodies evidence check
COVID-19 Critical Intelligence Unit: Monoclonal antibodies. 1. In brief Monoclonal antibodies 13 December 2021. Summary • Monoclonal antibodies are laboratory-made proteins that mimic or enhance the human immune. system response to fight against
Document | File size: 278.5 KB | Date: 13/12/2021
Surgery post COVID-19 evidence check
COVID-19 Critical Intelligence Unit: Surgery post COVID-19. 1. In brief. Surgery post COVID-19 11 February 2022. Summary. • Most of the available evidence on surgery following COVID-19 is in adults, and there is no evidence. yet available on the
Document | File size: 189.4 KB | Date: 11/02/2022
Organisation of emergency departments during COVID-19 evidence check
COVID-19 Critical Intelligence Unit 20 September 2021. 1. Evidence check 20 September 2021. Organisation of emergency departments during COVID-19. Evidence check question. What is the evidence to support surging the capacity of emergency departments
Document | File size: 373.3 KB | Date: 20/09/2021
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0010/675883/Evidence-Check-ED-models.pdf
Ocular transmission evidence check
COVID-19 Critical Intelligence Unit: Ocular transmission of COVID-19. 1. In brief. Ocular transmission 26 August 2021. Background. • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted person-to-person. through close contact
Document | File size: 156.6 KB | Date: 27/08/2021
AstraZeneca vaccine and blood clots evidence check
COVID-19 Critical Intelligence Unit: Evidence on AstraZeneca and blood clots. 1. In brief Emerging evidence on AstraZeneca vaccine and blood clots 17 March 2021. Background • AstraZeneca vaccine (AZD1222 / ChAdOx1) is a viral vector vaccine. It
Document | File size: 136.8 KB | Date: 17/03/2021
Children and COVID-19 outcomes evidence check
COVID-19 Critical Intelligence Unit: Children and COVID-19 outcomes. 1. In brief Children and COVID-19 outcomes 29 September 2021. Background • Early in the COVID-19 pandemic in Australia, very few children were admitted to hospital, with. only 44
Document | File size: 103.4 KB | Date: 29/09/2021